Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease.
Koprich JB, Reske-Nielsen C, Mithal P, Isacson O. · 2008
Read Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. by Koprich JB, Reske-Nielsen C, Mithal P, Isacson O. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2292163.txt.
Description
Koprich, Reske-Nielsen, Mithal and Isacson tested in 2008 whether inflammation makes dopamine neurons easier to kill in a rat model of Parkinson's disease. Parkinson's cause is unknown, though genes, toxins and ageing all contribute. The team gave rats a non-toxic dose of bacterial lipopolysaccharide, which provokes inflammation, then a low dose of the neuron toxin 6-OHDA. They measured immune signals, activated microglia and neuron loss, and tried blocking the interleukin-1 receptor.
The inflammatory dose raised cytokine secretion and primed dopamine neurons to die from the later weak toxin dose. Interleukin-1beta stood out among the raised signals, alongside microglial activation. Blocking its receptor cut other inflammatory molecules and significantly reduced the extra neuron loss. Inflammation thus behaves as a genuine risk factor that sensitises the exact neurons Parkinson's destroys. The pathway offers a possible target for slowing the disease.
Catalog record
| CREATOR | Koprich JB, Reske-Nielsen C, Mithal P, Isacson O. |
|---|---|
| YEAR | 2008 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |